09.11.14
Radiation therapy firm RaySearch Laboratories has received U.S. Food and Drug Administration 510(k) clearance to sell its pencil-beam scanning option for its RayStation 4.0 treatment planning system for proton therapy.The new version includes tools for optimizing proton treatments and was released in international markets in December 2013.
RaySearch believes that pencil-beam scanning is the most sophisticated form of proton therapy delivery, enabling intensity-modulated proton therapy that allows clinicians to target tumors by controlling both the intensity and spatial distribution with millimeter-level precision.
The new version includes all the tools needed for pencil-beam scanning, including multiple field optimization, single-field uniform dose, and distal edge-tracking techniques.
“We have won several orders and been the most successful supplier of solutions for proton treatment planning over the last year. Our position on the U.S. market becomes even stronger now that we have market clearance for all relevant techniques for proton therapy”, said Johan Löf, CEO of RaySearch.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines features such as multi-criteria optimization tools with full support for 4-D adaptive radiation therapy and includes functionality such as RaySearch’s algorithms for Intensity Modulated Proton Therapy and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy, the company noted. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories develops advanced software solutions for improved radiation therapy of cancer. The company was founded in 2000 as a spinoff from the Karolinska Institute in Stockholm, Sweden, and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
RaySearch believes that pencil-beam scanning is the most sophisticated form of proton therapy delivery, enabling intensity-modulated proton therapy that allows clinicians to target tumors by controlling both the intensity and spatial distribution with millimeter-level precision.
The new version includes all the tools needed for pencil-beam scanning, including multiple field optimization, single-field uniform dose, and distal edge-tracking techniques.
“We have won several orders and been the most successful supplier of solutions for proton treatment planning over the last year. Our position on the U.S. market becomes even stronger now that we have market clearance for all relevant techniques for proton therapy”, said Johan Löf, CEO of RaySearch.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines features such as multi-criteria optimization tools with full support for 4-D adaptive radiation therapy and includes functionality such as RaySearch’s algorithms for Intensity Modulated Proton Therapy and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy, the company noted. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories develops advanced software solutions for improved radiation therapy of cancer. The company was founded in 2000 as a spinoff from the Karolinska Institute in Stockholm, Sweden, and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.